Hydroxyapatite (HAP) has gained increasing attention in recent years as a potential alternative to fluoride in toothpaste. Especially in Europe and Asia, it is promoted as a promising ingredient that promotes tooth remineralization and prevents tooth decay. However, a closer look reveals that hydroxyapatite is not without its weaknesses, and no independent research supports its ability to replace the effectiveness of fluoride.
Scientific facts: What is hydroxyapatite?
Hydroxyapatite is a biocompatible material that is chemically similar to the main component of tooth enamel. It is made from synthetic or natural calcium phosphate and is intended to fill microscopic damage in tooth enamel by fitting in like a “paving” block. Manufacturers advertise that HAP smoothes the tooth surface, protects sensitive teeth, and is gentler than fluoride. A common marketing claim is that hydroxyapatite is the “main component of tooth enamel.” While this is true, it has no relevance for (or against) its effectiveness as a caries protector.
Independent media outlets such as medizin-transparent.at have also examined the available studies in detail and concluded that there is a lack of scientific evidence that dental care products containing hydroxyapatite can help with sensitive teeth or prevent tooth decay. medizin-transparent.at found only inadequate studies on these topics that lacked conclusiveness. The studies cannot provide evidence for the claimed effects (link).
What are the advantages of hydroxyapatite?
Proponents of HAP highlight several advantages:
- Biocompatibility: HAP is a natural component of tooth enamel and causes no known toxic side effects.
- Child-friendly: Because HAP is non-toxic, it is often advertised as safe for children, even if toothpaste is accidentally swallowed.
- Protection against hypersensitivity: Studies show that HAP can seal sensitive tooth necks and reduce pain sensitivity.
- Environmental friendliness: Because fluoride can be problematic in the environment, HAP is considered a “green” substitute.
What are the disadvantages of hydroxyapatite?
Despite its advantages, there are good reasons to remain skeptical:
- Inadequate long-term studies: While there are numerous small studies demonstrating the effectiveness of HAP, large-scale, independent, long-term clinical studies are lacking. In particular, it is unclear how well HAP protects against high caries susceptibility compared to fluoride.
- Mechanism of remineralization: Although HAP can repair microscopic damage in tooth enamel, it remains questionable how effectively this process actually occurs in the oral environment, where pH fluctuations, bacteria, and saliva play a role.
- Weaker caries protection: While HAP has shown protective effects compared to fluoride in several studies, fluoride has proven particularly effective in strengthening tooth enamel against acid attack and inhibiting bacterial processes.
- Cost and availability: Toothpastes containing HAP are often more expensive than fluoride-containing products and are not widely available, which makes acceptance difficult.
Misleading HAP marketing claims
A critical issue is the aggressive marketing of HAP as “better than fluoride.” Such claims are often based on studies funded by the manufacturers and omit important scientific limitations. Consumers, discouraged by negative headlines about fluoride (e.g., alleged toxicity), may hastily choose HAP products without questioning the scientific evidence.
Conclusion: HAP is a supplement rather than replacement
Hydroxyapatite is undoubtedly a promising active ingredient and offers an alternative, especially for certain target groups such as children, people with fluoride intolerance, or those at risk of caries. However, HAP should not be considered a blanket replacement for fluoride, but rather a complement in a diversified approach to dental care. To date, fluoride remains the gold standard, particularly due to its proven efficacy and decades of use in caries prevention.
The choice between hydroxyapatite and fluoride should not be determined by marketing trends, but rather by scientific evidence and the individual needs of the patient. It is essential that further independent, high-quality research be conducted before HAP can be recognized as an equivalent alternative.